Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 2,233 | 1,439 | 2,009 | 1,728 | 1,602 |
| Cost of Goods | 812 | 573 | 1,020 | 668 | 552 |
| Gross Profit | 1,421 | 866 | 989 | 1,060 | 1,050 |
| Operating Expenses | 10,075 | 9,316 | 9,826 | 8,288 | 8,038 |
| Operating Income | -7,842 | -7,877 | -8,817 | -6,560 | -6,436 |
| Interest Expense | -422 | 0 | 0 | -1,014 | 884 |
| Other Income | 520 | 1,332 | -75 | 0 | 0 |
| Pre-tax Income | -6,900 | -6,545 | -8,892 | -5,546 | -7,320 |
| Income Tax | 19 | 40 | -229 | 18 | 35 |
| Net Income Continuous | -6,919 | -6,585 | -8,663 | -5,564 | -7,355 |
| Net Income | $-6,919 | $-6,585 | $-8,663 | $-5,564 | $-7,355 |
| EPS Basic Total Ops | -0.28 | -0.27 | -0.41 | -0.26 | -0.35 |
| EPS Basic Continuous Ops | -0.28 | -0.27 | -0.41 | -0.26 | -0.35 |
| EPS Diluted Total Ops | -0.28 | -0.27 | -0.41 | -0.26 | -0.35 |
| EPS Diluted Continuous Ops | -0.28 | -0.27 | -0.41 | -0.26 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.26 | -0.42 | N/A | N/A |
| EBITDA(a) | $-7,608 | $-7,627 | $-8,735 | $-6,273 | $-6,159 |